Based on the Anti Obesity Drugs market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Anti Obesity Drugs market covered in Chapter 5:
Novo Nordisk
Pfizer
Bayer AG
F Hoffmann-La Roche
GlaxoSmithKline
Vivus
Currax Pharmaceuticals
In Chapter 6, on the basis of types, the Anti Obesity Drugs market from 2015 to 2025 is primarily split into:
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
In Chapter 7, on the basis of applications, the Anti Obesity Drugs market from 2015 to 2025 covers:
Prescription Drugs
OTC drugs
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Anti Obesity Drugs Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Novo Nordisk
5.1.1 Novo Nordisk Company Profile
5.1.2 Novo Nordisk Business Overview
5.1.3 Novo Nordisk Anti Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Novo Nordisk Anti Obesity Drugs Products Introduction
5.2 Pfizer
5.2.1 Pfizer Company Profile
5.2.2 Pfizer Business Overview
5.2.3 Pfizer Anti Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Pfizer Anti Obesity Drugs Products Introduction
5.3 Bayer AG
5.3.1 Bayer AG Company Profile
5.3.2 Bayer AG Business Overview
5.3.3 Bayer AG Anti Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Bayer AG Anti Obesity Drugs Products Introduction
5.4 F Hoffmann-La Roche
5.4.1 F Hoffmann-La Roche Company Profile
5.4.2 F Hoffmann-La Roche Business Overview
5.4.3 F Hoffmann-La Roche Anti Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 F Hoffmann-La Roche Anti Obesity Drugs Products Introduction
5.5 GlaxoSmithKline
5.5.1 GlaxoSmithKline Company Profile
5.5.2 GlaxoSmithKline Business Overview
5.5.3 GlaxoSmithKline Anti Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 GlaxoSmithKline Anti Obesity Drugs Products Introduction
5.6 Vivus
5.6.1 Vivus Company Profile
5.6.2 Vivus Business Overview
5.6.3 Vivus Anti Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Vivus Anti Obesity Drugs Products Introduction
5.7 Currax Pharmaceuticals
5.7.1 Currax Pharmaceuticals Company Profile
5.7.2 Currax Pharmaceuticals Business Overview
5.7.3 Currax Pharmaceuticals Anti Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Currax Pharmaceuticals Anti Obesity Drugs Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Anti Obesity Drugs Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Anti Obesity Drugs Sales and Market Share by Types (2015-2020)
6.1.2 Global Anti Obesity Drugs Revenue and Market Share by Types (2015-2020)
6.1.3 Global Anti Obesity Drugs Price by Types (2015-2020)
6.2 Global Anti Obesity Drugs Market Forecast by Types (2020-2025)
6.2.1 Global Anti Obesity Drugs Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Anti Obesity Drugs Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Anti Obesity Drugs Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Anti Obesity Drugs Sales, Price and Growth Rate of Peripherally Acting Anti-obesity Drugs
6.3.2 Global Anti Obesity Drugs Sales, Price and Growth Rate of Centrally Acting Anti-obesity Drugs
6.4 Global Anti Obesity Drugs Market Revenue and Sales Forecast, by Types (2020-2025)
Summary: Get latest Market Research Reports on Anti Obesity Drugs. Industry analysis & Market Report on Anti Obesity Drugs is a syndicated market report, published as Global Anti Obesity Drugs Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Anti Obesity Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.